Bernd Eisele
Algemeen Directeur bij Vakzine Projekt Management GmbH
Profiel
Bernd Eisele is the CEO of Vakzine Projekt Management GmbH since 2014.
Prior to this, he worked as the Director-International Products at Abbott Products GmbH.
He also worked as a Project Manager-Clinical at Behringwerke AG from 1988 to 1996.
Dr. Eisele holds a doctorate degree from Ruprecht-Karls-Universität Heidelberg, which he received in 1986.
Actieve functies van Bernd Eisele
Bedrijven | Functie | Begin |
---|---|---|
Vakzine Projekt Management GmbH
Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Algemeen Directeur | 16-11-2009 |
Eerdere bekende functies van Bernd Eisele
Bedrijven | Functie | Einde |
---|---|---|
Behringwerke AG
Behringwerke AG Pharmaceuticals: OtherHealth Technology Part of Sanofi, Behringwerke AG is a German company that produces specialty chemicals and pharmaceutical products. The company is based in Marburg, Germany. | Corporate Officer/Principal | 01-01-1996 |
Abbott Products GmbH | Corporate Officer/Principal | - |
Opleiding van Bernd Eisele
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Behringwerke AG
Behringwerke AG Pharmaceuticals: OtherHealth Technology Part of Sanofi, Behringwerke AG is a German company that produces specialty chemicals and pharmaceutical products. The company is based in Marburg, Germany. | Health Technology |
Vakzine Projekt Management GmbH
Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Health Technology |
Abbott Products GmbH |